Maya Poffenberger

Maya Poffenberger is a Senior Scientist specializing in Multispecific Antibody Therapeutics at Zymeworks Inc. since October 2018, where responsibilities include leading a team for a cytokine fusion pipeline project in oncology. Previously, Maya served as a Postdoctoral Fellow at McGill University, focusing on T cell-specific loss of LKB1 in gastrointestinal polyposis and hepatocellular carcinoma. Maya completed a PhD in Immunology at The University of British Columbia, investigating IL-6's role in coxsackievirus-induced autoimmune myocarditis. Early career experience includes research assistant positions at the University of Victoria and McGill University, with a solid foundation in mouse handling, molecular assays, and viral pathogenesis. Maya holds a BSc in Biochemistry and Microbiology from the University of Victoria.